Recombinant
RabMAb

Recombinant Anti-eIF5A antibody [EP526Y] (ab32443)

Reviews (1)Q&A (1)References (10)

Overview

  • Product name
    Anti-eIF5A antibody [EP526Y]
    See all eIF5A primary antibodies
  • Description
    Rabbit monoclonal [EP526Y] to eIF5A
  • Host species
    Rabbit
  • Tested applications
    Suitable for: IHC-FoFr, WB, IHC-P, Flow Cyt, IP, ICC/IFmore details
  • Species reactivity
    Reacts with: Mouse, Rat, Human, Drosophila melanogaster
  • Immunogen

    Synthetic peptide within Human eIF5A aa 1-100 (N terminal). The exact sequence is proprietary.
    Database link: P63241

  • Positive control
    • Jurkat and HeLa whole cell lysate (ab150035) and Adenocarcinoma of human uterus slides.
  • General notes

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents.

    This product is a recombinant rabbit monoclonal antibody.

Properties

Applications

Our Abpromise guarantee covers the use of ab32443 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-FoFr 1/400. PubMed: 19546244
WB 1/5000 - 1/10000. Predicted molecular weight: 18 kDa.
IHC-P Use at an assay dependent concentration.
Flow Cyt 1/50 - 1/80.

ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.
IP 1/50.
ICC/IF 1/500.

Target

  • Function
    mRNA-binding protein involved in translation elongation. Has an important function at the level of mRNA turnover, probably acting downstream of decapping. Involved in actin dynamics and cell cycle progression, mRNA decay and probably in a pathway involved in stress response and maintenance of cell wall integrity. With syntenin SDCBP, functions as a regulator of p53/TP53 and p53/TP53-dependent apoptosis. Regulates also TNF-alpha-mediated apoptosis. Mediates effects of polyamines on neuronal process extension and survival. May play an important role in brain development and function, and in skeletal muscle stem cell differentiation. Also described as a cellular cofactor of human T-cell leukemia virus type I (HTLV-1) Rex protein and of human immunodeficiency virus type 1 (HIV-1) Rev protein, essential for mRNA export of retroviral transcripts.
  • Tissue specificity
    Expressed in umbilical vein endothelial cells and several cancer cell lines (at protein level).
  • Sequence similarities
    Belongs to the eIF-5A family.
  • Post-translational
    modifications
    eIF-5A seems to be the only eukaryotic protein to have an hypusine residue which is a post-translational modification of a lysine by the addition of a butylamino group (from spermidine).
  • Cellular localization
    Cytoplasm. Nucleus. Endoplasmic reticulum membrane. Nucleus > nuclear pore complex. Hypusine modification promotes the nuclear export and cytoplasmic localization and there was a dynamic shift in the localization from predominantly cytoplasmic to primarily nuclear under apoptotic inducing conditions.
  • Information by UniProt
  • Database links
    see all
  • Alternative names
    • eIF 4D antibody
    • eIF 5A 1 antibody
    • EIF 5A antibody
    • eIF 5A1 antibody
    • eIF-4D antibody
    • eIF-5A antibody
    • eIF-5A-1 antibody
    • eIF-5A1 antibody
    • eIF4D antibody
    • eif5a antibody
    • EIF5A1 antibody
    • eIF5AI antibody
    • Eukaryotic initiation factor 5A antibody
    • Eukaryotic initiation factor 5A isoform 1 antibody
    • Eukaryotic translation initiation factor 5A 1 antibody
    • Eukaryotic translation initiation factor 5A antibody
    • Eukaryotic translation initiation factor 5A-1 antibody
    • IF5A1_HUMAN antibody
    • MGC104255 antibody
    • MGC99547 antibody
    • Rev binding factor antibody
    • Rev-binding factor antibody
    • uORF A antibody
    • uORF antibody
    see all

Images

  • Western blot - Anti-eIF5A antibody [EP526Y] (ab32443)
    Western blot - Anti-eIF5A antibody [EP526Y] (ab32443)
    Anti-eIF5A antibody [EP526Y] (ab32443) at 1/10000 dilution + Jurkat cell lysate.

    Predicted band size: 18 kDa
    Observed band size: 18 kDa

  • Immunocytochemistry/ Immunofluorescence - Anti-eIF5A antibody [EP526Y] (ab32443)
    Immunocytochemistry/ Immunofluorescence - Anti-eIF5A antibody [EP526Y] (ab32443)

    Immunocytochemistry/Immunofluorescence analysis of HeLa (human cervix adenocarcinoma) cells labelling eIF5A with purified ab32443 at 1/500. Cells were fixed with 4% Paraformaldehyde. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG (ab150077) at 1/1000 dilution was used as the secondary antibody. Nuclei couterstained with DAPI (blue). 

    Secondary Only Control: PBS was used instead of the primary antibody as the negative control

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-eIF5A antibody [EP526Y] (ab32443)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-eIF5A antibody [EP526Y] (ab32443)
    ab32443 at a 1:250 dilution staining eIF5A in human adenocarcinoma of uterus using Immunohistochemistry, Paraffin Embedded Tissue.
  • Flow Cytometry - Anti-eIF5A antibody [EP526Y] (ab32443)
    Flow Cytometry - Anti-eIF5A antibody [EP526Y] (ab32443)
    Overlay histogram showing Jurkat cells stained with ab32443 (red line). The cells were fixed with methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab32443, 1/50 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit monoclonal IgG (0.5µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in Jurkat cells fixed with 4% paraformaldehyde (10 min)/permeabilized in 0.1% PBS-Tween used under the same conditions.

References

This product has been referenced in:
  • Wang Z  et al. EIF5A regulates proliferation and chemoresistance in pancreatic cancer through the sHH signalling pathway. J Cell Mol Med 23:2678-2688 (2019). Read more (PubMed: 30761741) »
  • Zhang J  et al. EIF5A1 promotes epithelial ovarian cancer proliferation and progression. Biomed Pharmacother 100:168-175 (2018). WB . Read more (PubMed: 29428664) »
See all 10 Publications for this product

Publishing research using ab32443? Please let us know so that we can cite the reference in this datasheet.

Customer reviews and Q&As

Show All Reviews Q&A
Submit a review Submit a question

1-2 of 2 Abreviews or Q&A

Question

Will this cross-react with human EIF5A2?
http://www.uniprot.org/uniprot/Q9GZV4

Read More
Answer

Thank you for contacting us.

The immunogen shares 74% identity with human EIF5A2, so it is not predicted to cross-react.

Please do not hesitate to contact us if you need any more advice or information.

Read More

Western blot abreview for Anti-eIF5A antibody [EP526Y]

 Good
Abreviews
Application
Western blot
Sample
Human Cell lysate - whole cell (HCT116 colon cancer cell line)
Loading amount
30 µg
Specification
HCT116 colon cancer cell line
Blocking step
Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% in TBST
Read More

Abcam user community

Verified customer

Submitted Nov 07 2006

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up